Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort
Clinical trial NCT03900442 · COMPLETED
Trial details
- NCT number
- NCT03900442
- Sponsor
- Prescient Therapeutics, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2025-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.